Long Term Vitamin D Therapy in HCV Treated Patients
Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Treatment of hepatitis C virus (HCV) infection was carried out using pegylated interferon
(PEG-IFN), ribavirin (RBV) and vitamin D (vit D) for 48 weeks in HCV genotypes 4a subjects.
The purpose of this study is to determine the effect of vitamin D on liver affection in such
patients.
Phase:
Phase 3
Details
Lead Sponsor:
Dr. Nadia AbdelAaty AbdelKader
Treatments:
Ergocalciferols Interferons Ribavirin Vitamin D Vitamins